Ukubeka iliso okuNtsha okuNgqongileyo kwabantu abaPhila ngokuFanelwa yiNtliziyo

A BAMBA FreeRelease 2 e1645498498135 | eTurboNews | eTN
Ibhalwe ngu Linda Hohnholz

U-Abbott namhlanje ubhengeze ukuba i-US Food and Drug Administration (FDA) ivume isalathiso esandisiweyo seCardioMEMS ™ HF System yenkampani ukuxhasa ukhathalelo lwabantu abaninzi abaphila nokusilela kwentliziyo. Ngesalathiso esandisiweyo, i-1.2 yezigidi zezigulane zase-US1 ngoku zifanelekile ukuba zixhamle kuhlolo oluphezulu kunye ne-CardioMEMS sensor, ephawula ukwanda okubalulekileyo kuluntu lwangoku olunokulungiswa. Inzwa ibonelela ngenkqubo yokulumkisa kwangaphambili evumela oogqirha ukuba bakhusele ngokuchasene nokungaphumeleli kwentliziyo.

Ngaphezu kwe-6.2 yezigidi zaseMelika zine-heart failure2, kunye nokuxilongwa okuqikelelwa ukuba kuphindwe kabini nge-3. Nangona ukungaphumeleli kwentliziyo kuyisifo esingapheliyo, iinketho zonyango ezifana neCardioMEMS zinokubonelela izigulane kunye noogqirha babo ngolwazi olusebenzayo lokunceda ukulawula ukungaphumeleli kwentliziyo ngaphambi kokuba iqhubele phambili kwinqanaba elilandelayo. . I-sensor ye-CardioMEMS sisixhobo sobungakanani be-paperclip, xa sibekwe kwi-pulmonary artery ngexesha lenkqubo encinci, ihlola utshintsho lwexinzelelo olubonisa ukungaphumeleli kwentliziyo. Isensom idlulisela ufundo loxinzelelo lwemihla ngemihla kwiqela lekliniki yesigulana ngaphandle kwamacingo- ivumela oogqirha ukuba benze utshintsho lonyango ukulwa nokuqhubekela phambili ukuya kwinqanaba lamva lokungaphumeleli kwentliziyo ngelixa bexhobisa isigulana ukuba silawule imeko yabo naphi na.

Inkqubo ye-CardioMEMS ye-HF yaqala ukuvunywa kwi-2014 ukuba isetyenziswe kwi-New York Heart Association (NYHA) i-Class III yezigulane ze-heart failure kunye ne-heart failure hospital in the last year. Isalathiso esitsha sivumela i-sensor ye-CardioMEMS ukuba isetyenziswe ngabantu abaphila ne-Class II ye-heart failure kunye nezigulane ezifumana uvavanyo lwegazi olubonisa amanqanaba aphezulu e-biomarkers eyaziwa ngokuba yi-natriuretic peptides, ebonisa ukungaphumeleli kwentliziyo.

“Ukusilela kwentliziyo lugqatso oluchasene nexesha apho sihlala sisemva kuba izigulana azifumani khathalelo kwangethuba,” utshilo uPhilip B. Adamson, MD, igosa eliyintloko lezonyango kwishishini lika-Abbott lokusilela kwentliziyo. “Olu phawu lwandisiweyo luthetha ukuba oogqirha banokunyanga abantu abangakumbi abanengxaki yentliziyo ekwinqanaba langaphambili, benikela ithuba lokuthintela ukubandezeleka okungakumbi yaye mhlawumbi baphephe ukuqhubela phambili okunokuba nempembelelo enzulu kumgangatho wobomi bomntu.”

INTO ONOKUYITHATHA KWELI NQAKU:

  • Isalathiso esitsha sivumela i-sensor ye-CardioMEMS ukuba isetyenziswe ngabantu abaphila ne-Class II ye-heart failure kunye nezigulane ezifumana uvavanyo lwegazi olubonisa amanqanaba aphezulu e-biomarkers eyaziwa ngokuba yi-natriuretic peptides, ebonisa ukungaphumeleli kwentliziyo.
  • Ngelixa ukungaphumeleli kwentliziyo kusisifo esingapheliyo, ukhetho lwezonyango olufana neCardioMEMS lunokubonelela izigulane kunye noogqirha babo ngolwazi olusebenzayo lokunceda ukulawula ukungaphumeleli kwentliziyo ngaphambi kokuba iqhubele phambili kwixesha elizayo.
  • Inkqubo ye-CardioMEMS ye-HF yaqala ukuvunywa kwi-2014 ukuba isetyenziswe kwi-New York Heart Association (NYHA) i-Class III yezigulane ze-heart failure kunye ne-heart failure yangaphambili esibhedlele kunyaka odlulileyo.

<

Malunga nombhali

Linda Hohnholz

Umhleli oyintloko we eTurboNews esekwe kwi-eTN HQ.

Bhlisa
Yaziswe ngawo
guest
0 izimvo
Inline feedbacks
Jonga zonke izimvo
0
Ndingazithanda iingcinga zakho, nceda uphawule.x
Yabelana ku...